Emergency Management of Anaphylaxis from Wasp Stings
Immediately administer intramuscular epinephrine 0.01 mg/kg (up to 0.3 mg for this 8-year-old) into the anterolateral thigh and transport to the emergency department—this child is experiencing anaphylaxis with urticaria and syncope, which represents a life-threatening systemic reaction requiring urgent epinephrine as first-line treatment. 1
Immediate Actions
The combination of hives (urticaria) and syncope after wasp stings constitutes anaphylaxis, not just a cutaneous reaction. Syncope indicates cardiovascular involvement and potential progression to shock. The evidence is unequivocal that delayed epinephrine administration is associated with fatal outcomes 1.
Epinephrine Administration
- Dose: 0.01 mg/kg, maximum 0.3 mg in children 1
- Route: Intramuscular injection into the mid-outer thigh (anterolateral aspect) 1, 2
- This route achieves more rapid and higher plasma concentrations than subcutaneous or deltoid injection
- Spring-loaded autoinjectors (EpiPen) provide dose-equivalent levels to syringe administration 2
- Repeat dosing: May be required every 5 minutes if symptoms persist or recur 1, 2
- No contraindications: Even in patients with cardiovascular disease or on beta-blockers, the risk of anaphylaxis exceeds the risk of epinephrine 1
Critical Pitfall
Antihistamines and corticosteroids are NOT substitutes for epinephrine 1. While they may be used as adjunctive therapy, they should never delay or replace epinephrine administration. Fatal anaphylaxis cases consistently show delayed or absent epinephrine use 1.
Supportive Care
- Remove any visible stingers by flicking or scraping (do not grasp the venom sac, which injects additional venom) 1
- Administer oxygen if available
- Position patient supine with legs elevated (if tolerated and not compromising airway)
- Transport to emergency department for observation (reactions can be biphasic or protracted) 1
Post-Acute Management
Mandatory Follow-up Actions
After stabilization, this child requires:
Prescription for epinephrine autoinjector at appropriate dose for weight 1
- Patient and caregivers must be trained on proper use and indications
- Should be carried at all times
Referral to allergist-immunologist 1
- For specific IgE testing (skin testing or serum venom-specific IgE)
- To evaluate candidacy for venom immunotherapy (VIT)
- Testing should occur 2-6 weeks after the reaction for optimal sensitivity
Consider medical identification bracelet 1
Venom Immunotherapy Indication
This child is a candidate for VIT because the reaction extended beyond isolated cutaneous symptoms to include syncope (cardiovascular involvement). VIT is highly effective, reducing the risk of future severe reactions by up to 75-95% 3, 4. The guideline evidence strongly supports VIT for children with anaphylaxis that goes beyond urticaria alone 1, 5.
Important distinction: Children with reactions limited strictly to skin (generalized urticaria without other systemic symptoms) have very low risk of severe future reactions and typically do not require VIT 6, 5. However, this child's syncope places them in the high-risk category requiring immunotherapy.
Avoidance Education
Provide specific instructions:
- Avoid walking barefoot outdoors or wearing open shoes
- Wear long pants, long sleeves, and closed shoes when outdoors
- Avoid brightly colored clothing and floral prints
- Stay away from garbage containers, picnic areas, and known nests
- Do not drink from opaque containers outdoors (insects may be inside)
- Have professional removal of any nests near the home 1
Why This Matters for Mortality
The presence of syncope indicates this was not a mild cutaneous reaction but true anaphylaxis with cardiovascular compromise. Without prompt epinephrine and appropriate long-term management including VIT, this child faces approximately 50-75% risk of another systemic reaction if stung again 3. VIT reduces this risk dramatically and is potentially life-saving 4, 5.